In accordance with 21 cfr 803.22 (b)(2), we are notifying you that on february 28, 2013, a nurse reported a patient was hospitalized on (b)(6) 2013, with diabetic ketoacidosis.He experienced recurrent e4 occlusion and e7 electronic errors on the infusion device.He was unwell and not very responsive, and he was treated with an insulin drip.This occurred in the united kingdom and was reported by an affiliate, and the patient's information was not provided.The cleo infusion set mentioned in this event is not manufactured by our firm.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|